Henry Ford Health System
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Henry Ford Health System sits in the top decile of US sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count).
Henry Ford Health System: 234 sponsored US clinical trials, 43 recruiting.
Henry Ford Health System sponsors 234 registered US clinical trials on ClinicalTrials.gov, 43 of them currently recruiting, and 148 completed. 35 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Insomnia, with 5 trials.
Top-decile sponsor footprint
Henry Ford Health System ranks in the top decile of sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
148 of 173 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
234 total, page 3 of 5
Pleth Variability Index (PVI) as a Measure of Volume Status During Transcatheter Mitral Valve Repair
NCT03993938
Compression Wraps as Adjuvant Therapy in Management of Acute Systolic Heart Failure
NCT04095416
Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae
NCT03858543
The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation
NCT03887377
Mesothelioma Early Detection by VOCs
NCT04106973
The Improving ATTENDance to Cardiac Rehabilitation Trial
NCT03646760
Preoperative Hip Knee Anxiety Sleep Study
NCT04180527
Nonopioid Analgesia After Rotator Cuff Repair
NCT03818919
Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction
NCT03818932
Nonopioid Analgesia After Arthroscopic Meniscus Surgery
NCT03820193
TEE Image Quality Improvement With Our Devised Probe Cover
NCT03812185
Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma
NCT03958006
B/F/TAF Ease of Swallowability Trial
NCT04600687
The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown
NCT03929224
Subscapularis Strength After Total Shoulder Arthroplasty
NCT03854357
A Brief Intervention for Chronic Pain in Primary Care
NCT03692468
Insomnia and Rumination in Late Pregnancy and the Risk for Postpartum Depression
NCT03596879
The Fruit and Vegetable Prescription Program Study
NCT04597957
Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs
NCT03312517
Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant
NCT03850379
The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects
NCT03065582
Sleep To Reduce Incident Depression Effectively
NCT03322774
Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo
NCT05238077
Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function
NCT03814031
Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis Suppurativa
NCT05830149
Remote Ischemic Preconditioning for Renal Protection in TAVI
NCT03347032
Topical Capsaicin for Cyclical Vomiting
NCT03223350
Effect of Emergency Department Bedside Compression Ultrasonography on Door-to-Disposition Time in Patients Suspicious for Lower Extremity Deep Venous Thrombosis
NCT05682040
Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients
NCT03180398
Adaptive Cardiac Resynchronization Therapy in Patients With RBBB
NCT05936294
A Brief Intervention for Patients on Opioids for Acute Pain
NCT05658926
Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty
NCT03375112
Effects of Preoperative Carbohydrate Rich Drinks on Immediate Postoperative Outcome in Total Knee Arthroplasty
NCT03380754
Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer
NCT03281382
Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer
NCT03269344
Achilles Tendon Lengthening With Traditional vs. Accelerated Rehab
NCT04050748
Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes
NCT02850224
Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy
NCT03250507
Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery
NCT03037515
Does Transesophageal Echocardiography Along With an Orogastric Tube Improve the Image Quality Intraoperatively?
NCT03454399
Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty
NCT02980926
Emergency Department, Rapid Assessment for Sexually Transmitted Infection
NCT02386514
Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy
NCT02796365
National Cardiogenic Shock Initiative
NCT03677180
Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength
NCT03033589
Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?
NCT02740192
Sleep to Prevent Evolving Affecting Disorders
NCT02988375
Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction
NCT02762825
The Efficacy of Bakuchiol in Treating PIH
NCT06833996
An In Vivo Model for Postinflammatory Hyperpigmentation
NCT02905903
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 15 |
| Phase 2 | 23 |
| Phase 3 | 9 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the Henry Ford Health System pipeline
43 recruiting of 234 indexed (18% open); 148 completed (63%).
Phase mix: 35 late (III/IV) vs 38 early (I/II) (balanced across stages).
Top condition: Insomnia (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Henry Ford Health System: open-pipeline peers nationwide
Peers matched on 234 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Henry Ford Health System sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 234 trials (± recruiting share)
- Daiichi Sankyo · 236 trials · 12% recruiting
- Loma Linda University · 237 trials · 15% recruiting
- Brown University · 231 trials · 15% recruiting
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- New York Institute of Technology · 18% recruiting · 49 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of California, San Diego · 18% recruiting · 775 trials
Related
What to do with this Henry Ford Health System page
234 registered trials is a research-attention snapshot, not an endorsement of Henry Ford Health System or any single study.
- 43 of Henry Ford Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Insomnia is the condition Henry Ford Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Insomnia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Henry Ford Health System pipeline card: 234 registered trials from official public datasets.Report a data error.